Jae Yeon Hwang Selected Research

Colonic Neoplasms (Colon Cancer)

1/2015

Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell Growth via Inhibition of the ERK-Dependent EGF Receptor Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae Yeon Hwang Research Topics

Disease

5	Neoplasms (Cancer) 01/2024 - 08/2016
4	Psychotic Disorders (Schizoaffective Disorder) 03/2022 - 01/2010
4	Schizophrenia (Dementia Praecox) 11/2016 - 04/2012
2	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2019
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 05/2017 - 09/2011
1	Non-alcoholic Fatty Liver Disease 10/2023
1	Liver Diseases (Liver Disease) 10/2023
1	Hypersensitivity (Allergy) 03/2022
1	Asthma (Bronchial Asthma) 03/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Extravasation of Diagnostic and Therapeutic Materials 01/2022
1	Fistula 01/2022
1	Hemorrhage 01/2022
1	Cognitive Dysfunction 01/2022
1	Carcinogenesis 12/2021
1	Dementia (Dementias) 03/2021
1	Tibial Plateau Fractures 03/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2016
1	Alzheimer Disease (Alzheimer's Disease) 03/2016
1	Inflammation (Inflammations) 03/2016
1	Gliosis 03/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Nephritis 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2015
1	Edema (Dropsy) 05/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2014
1	Tobacco Use Disorder (Nicotine Dependence) 04/2014
1	Cerebral Cortical Thinning 09/2012

Drug/Important Bio-Agent (IBA)

3	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 02/2012
2	Circular RNAIBA 01/2024 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2016
2	LipopolysaccharidesIBA 03/2016 - 01/2016
2	Indicators and Reagents (Reagents)IBA 09/2012 - 04/2012
1	MicroRNAs (MicroRNA)IBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2024
1	Polychlorinated Biphenyls (PCBs)IBA 10/2023
1	Protein Isoforms (Isoforms)IBA 10/2023
1	6-methyladenineIBA 10/2023
1	RNA Splicing FactorsIBA 10/2023
1	GadoliniumIBA 03/2022
1	IodidesIBA 03/2022
1	isoamylamineIBA 01/2022
1	LipidsIBA 12/2021
1	Trastuzumab (Herceptin)FDA Link 12/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2021
1	Memantine (Namenda)FDA Link 03/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	LuciferasesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Glucose (Dextrose)FDA LinkGeneric 08/2016
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 08/2016
1	Sirolimus (Rapamycin)FDA Link 08/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2016
1	Caspase 3 (Caspase-3)IBA 08/2016
1	Chemokine ReceptorsIBA 03/2016
1	Amyloid beta-PeptidesIBA 03/2016
1	CC ChemokinesIBA 01/2016
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2015
1	Interleukin-8 (Interleukin 8)IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Cetuximab (Erbitux)FDA Link 01/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Ether (Diethyl Ether)IBA 05/2014
1	tricinIBA 05/2014
1	Carbon MonoxideIBA 04/2014
1	Olanzapine (Zyprexa)FDA Link 11/2012
1	sertindole (Serdolect)IBA 11/2012
1	Temazepam (Nocturne)FDA LinkGeneric 09/2012
1	Prednisolone (Predate)FDA LinkGeneric 04/2012
1	Escitalopram FDA Link 09/2011
1	Clozapine (Clozaril)FDA LinkGeneric 01/2010
1	Cocaine (Cocaine HCl)IBA 01/2010

Therapy/Procedure

2	Aftercare (After-Treatment) 03/2019 - 04/2014
2	Drug Therapy (Chemotherapy) 05/2017 - 02/2012
1	Stents 01/2022
1	Radiotherapy 01/2022
1	Chemoradiotherapy 01/2022
1	Therapeutics 03/2021
1	Renal Dialysis (Hemodialysis) 03/2018
1	Meditation 03/2018
1	Vocational Rehabilitation 11/2016
1	Intraperitoneal Injections 01/2016